LFVN$5.83-0.68%
Lifevantage Corp
Sector: Pharmaceutical PreparationsIndustry: Packaged FoodsCountry: USExchange: Nasdaq
Mkt Cap:$73.4M
Float & O/S:
Inst Own:
DilutionScan read 20 of Lifevantage Corp's SEC filings and found 1 shelf registration on file for LFVN. The latest dilution event on file is a registration statement on Mar 20, 2026. Analysis updated Oct 7, 2026.
Signal8 Summary
LFVN
Profitable small-cap at a discount
Snapshot
LifeVantage is a profitable small-cap supplement maker with strong margins but recent growth headwinds. In FY 2025, the company generated $228.5M in revenue (up 14.2% YoY) and $9.8M in net income, maintaining a healthy 80.4% gross margin. It produces solid free cash flow of $10.5M and holds $20.2M in cash against $11.7M in debt.
What's Happening Right Now
- : Q3 2026 revenue fell 25.2% year-over-year to $43.7M, missing analyst estimates and signaling a slowdown in growth.
- : The company declared a quarterly cash dividend of $0.05 per share, payable in June 2026.
- : LifeVantage received a U.S. patent for its Healthy Glow Essentials Stack, protecting its cellular signaling supplement formula.
- : Terrence Moorehead is set to become the new CEO and join the board on August 5, 2026, replacing current leadership.
- : The company announced it will expand its business footprint into Portugal, launching in May 2026.
